BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18845407)

  • 21. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
    Mijatovic V; van der Mooren MJ; Kenemans P; de Valk-de Roo GW; Netelenbos C
    Menopause; 1999; 6(2):134-7. PubMed ID: 10374220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study.
    Grady D; Brown JS; Vittinghoff E; Applegate W; Varner E; Snyder T;
    Obstet Gynecol; 2001 Jan; 97(1):116-20. PubMed ID: 11152919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of estriol treatment per vaginam before Burch culposuspension].
    Palomba S; Napolitano V; Sammartino A; Di Spiezio Sardo A; Vassallo M; Mandato V; Ruoto M; Acunzo G; Votino C; Nappi C
    Minerva Ginecol; 2001 Apr; 53(2):141-5. PubMed ID: 11319508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens.
    Sartori MG; Baracat EC; Girão MJ; Gonçalves WJ; Sartori JP; de Lima GR
    Int J Gynaecol Obstet; 1995 May; 49(2):165-9. PubMed ID: 7649322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
    Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women.
    Capobianco G; Wenger JM; Meloni GB; Dessole M; Cherchi PL; Dessole S
    Arch Gynecol Obstet; 2014 Mar; 289(3):601-8. PubMed ID: 24057079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transvaginal color Doppler sonographic assessment of uterus and ovaries in postmenopausal women: the effect of local estrogen treatment.
    Manonai J; Chittacharoen A; Theppisai U
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):222-6. PubMed ID: 16513246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fate of a large bolus of exogenous estrogen administered to postmenopausal women.
    Greenblatt RB; Natrajan PK; Aksu MF; Tzingounis VA
    Maturitas; 1980 Jan; 2(1):29-35. PubMed ID: 6250009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of estrogen with and without progestin on urinary incontinence.
    Hendrix SL; Cochrane BB; Nygaard IE; Handa VL; Barnabei VM; Iglesia C; Aragaki A; Naughton MJ; Wallace RB; McNeeley SG
    JAMA; 2005 Feb; 293(8):935-48. PubMed ID: 15728164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen effects on the urethra: beneficial effects in women with genuine stress incontinence.
    Elia G; Bergman A
    Obstet Gynecol Surv; 1993 Jul; 48(7):509-17. PubMed ID: 8355926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
    Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
    Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women.
    Iosif CS
    Arch Gynecol Obstet; 1992; 251(3):115-20. PubMed ID: 1605675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
    Bonduki CE; Lourenço DM; Baracat E; Haidar M; Noguti MA; da Motta EL; Lima GR
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):330-3. PubMed ID: 9539282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen.
    Vardy MD; Lindsay R; Scotti RJ; Mikhail M; Richart RM; Nieves J; Zion M; Cosman F
    Am J Obstet Gynecol; 2003 Jul; 189(1):81-8. PubMed ID: 12861143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens.
    Lundström E; Wilczek B; von Palffy Z; Söderqvist G; von Schoultz B
    Climacteric; 2001 Mar; 4(1):42-8. PubMed ID: 11379377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.
    Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):571-6. PubMed ID: 14699021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.